Hypersomatotropism and insulin-resistant diabetes mellitus in a cat.
In this report, we described the clinical, radiographic, and echocardiographic findings in a cat with hypersomatotropism and insulin-resistant diabetes mellitus. Growth hormone determinations were made because of persistent hyperglycemia despite insulin requirements exceeding 2.2 U/kg of body weight, and the acromegalic features of the cat. Also, the results of a therapeutic trial in which a long-acting analogue of somatostatin was used are discussed.
Morrison
S A
SA
Department of Clinical Sciences, New York State College of Veterinary Medicine, Cornell University, Ithaca 14853.
Randolph
J
J
Lothrop
C D
CD
D000172:Acromegaly / Q000662:veterinary; D000818:Animals; D002371:Cat Diseases; D002415:Cats; D003922:Diabetes Mellitus, Type 1 / Q000662:veterinary*; D013006:Growth Hormone / Q000378:metabolism*; D006943:Hyperglycemia / Q000662:veterinary; D007333:Insulin Resistance; D008297:Male
D013006:Growth Hormone